Trelegy Ellipta 200/62.5/25/Mcg Inhaler 30/Doses

236.8

Sku : I-033618
Key features
Trelegy Ellipta 200/62.5/25 mcg is a combination inhalation powder used for long-term management of chronic obstructive pulmonary disease (COPD) and asthma. Contains three active ingredients: fluticasone furoate (inhaled corticosteroid), umeclidinium (long-acting muscarinic antagonist), and vilanterol (long-acting beta-agonist) for comprehensive respiratory control. Helps reduce inflammation, relax airway muscles, and improve breathing over a 24-hour period. Delivered via the Ellipta inhaler for precise dosing and ease of use. Pack contains 30 doses, providing approximately one month of treatment when used once daily. How To Use: Use exactly as prescribed by your healthcare professional, typically once daily at the same time each day. Open the cover of the Ellipta inhaler to prepare a dose and inhale deeply through the mouthpiece. Do not exhale into the inhaler or shake it before use. Rinse your mouth with water after inhalation to reduce the risk of oral thrush. Follow your doctor’s instructions regarding regular monitoring and use of other COPD or asthma medications. Warnings And Precautions: Not recommended for sudden asthma attacks or acute respiratory distress. Use with caution in patients with heart disease, high blood pressure, or thyroid disorders. Report any signs of worsening breathing, chest pain, or allergic reactions immediately. Do not stop treatment abruptly without consulting your healthcare provider. Keep out of reach of children and store at room temperature away from moisture and heat. Ingredients: Active ingredients: Fluticasone furoate 200 mcg, Umeclidinium 62.5 mcg, Vilanterol 25 mcg per inhalation. Inactive excipients to stabilize the powder and ensure proper aerosolization. Ellipta inhaler device components made of medical-grade plastic and metal. Other pharmaceutical-grade excipients approved for inhalation use. No preservatives are included in the inhalation powder.

Description

Trelegy Ellipta 200/62.5/25 mcg is a combination inhalation powder used for long-term management of chronic obstructive pulmonary disease (COPD) and asthma. Contains three active ingredients: fluticasone furoate (inhaled corticosteroid), umeclidinium (long-acting muscarinic antagonist), and vilanterol (long-acting beta-agonist) for comprehensive respiratory control. Helps reduce inflammation, relax airway muscles, and improve breathing over a 24-hour period. Delivered via the Ellipta inhaler for precise dosing and ease of use. Pack contains 30 doses, providing approximately one month of treatment when used once daily. How To Use: Use exactly as prescribed by your healthcare professional, typically once daily at the same time each day. Open the cover of the Ellipta inhaler to prepare a dose and inhale deeply through the mouthpiece. Do not exhale into the inhaler or shake it before use. Rinse your mouth with water after inhalation to reduce the risk of oral thrush. Follow your doctor’s instructions regarding regular monitoring and use of other COPD or asthma medications. Warnings And Precautions: Not recommended for sudden asthma attacks or acute respiratory distress. Use with caution in patients with heart disease, high blood pressure, or thyroid disorders. Report any signs of worsening breathing, chest pain, or allergic reactions immediately. Do not stop treatment abruptly without consulting your healthcare provider. Keep out of reach of children and store at room temperature away from moisture and heat. Ingredients: Active ingredients: Fluticasone furoate 200 mcg, Umeclidinium 62.5 mcg, Vilanterol 25 mcg per inhalation. Inactive excipients to stabilize the powder and ensure proper aerosolization. Ellipta inhaler device components made of medical-grade plastic and metal. Other pharmaceutical-grade excipients approved for inhalation use. No preservatives are included in the inhalation powder.

Medical Disclaimer

The information in this product description is drawn from trusted pharmaceutical sources and is provided for general health education only. It is not a substitute for professional medical advice, diagnosis or treatment. Always read the leaflet inside the medicine pack and consult your pharmacist or doctor before starting, changing or stopping any medication. Almujtama Pharmacy accepts no liability for reliance on this information in place of direct medical advice.